Excision BioTherapeutics
Participants who receive EBT-101 in a parent protocol will be eligible to participate in this long-term follow-up (LTFU) study (EBT-101-002).
Participants who receive EBT-101 in a parent protocol will be eligible to participate in this LTFU study (EBT-101-002). All participants will have follow-up visits every six months until Year 5 post EBT-101. Thereafter, all participants will have follow-up visits annually on the anniversary of EBT-101 administration until study completion at Year 15.
Inclusion Criteria: * Willing and able to provide written, signed informed consent * Participants who received the investigational study intervention EBT-101 in a parent study Exclusion Criteria: • Participants who did not receive EBT-101 in a parent study
Long term follow up of participants who received EBT-101
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.